Biocon has a buy signal in all formats.
With the recent USFDA inspection observations, it may react to a low of 300. It may happen if the support at 314 is breached.
And, a bounce is expected to new levels, beyond 321.
With the recent USFDA inspection observations, it may react to a low of 300. It may happen if the support at 314 is breached.
And, a bounce is expected to new levels, beyond 321.
Komen:
One of the insider sold shares at 310, the reason behind the fall.